checkAd
    Startseite > Aktien > HOOKIPA Pharma > Nachrichten
    HOOKIPA Pharma Aktie
    0,8154
     
    USD
    +0,54 %
    +0,0044 USD
    Letzter Kurs 18.05.24 Nasdaq
    0,8154
     
    USD
    1.300 STK
    Geldkurs 17.05.24
    0,8250
     
    USD
    700 STK
    Briefkurs 17.05.24
    ISIN: US43906K1007 · WKN: A2PGMT · SYM: HOOK · USA

    Neueste Nachrichten

    HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
    09.05.24 · globenewswire · HOOKIPA Pharma
    HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab
    25.04.24 · globenewswire · HOOKIPA Pharma
    HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers
    24.04.24 · globenewswire · HOOKIPA Pharma
    HOOKIPA Pharma Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
    16.04.24 · globenewswire · HOOKIPA Pharma
    HOOKIPA Pharma to Host Investor Call on HB-200 and Planned Path to Registration
    10.04.24 · globenewswire · HOOKIPA Pharma
    HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
    22.03.24 · globenewswire · HOOKIPA Pharma
    HOOKIPA Pharma to Participate in Leerink Partners Global Biopharma Conference
    06.03.24 · globenewswire · HOOKIPA Pharma
    HOOKIPA Pharma Provides Update on Business Priorities and Oncology Partnership Programs
    29.01.24 · globenewswire · HOOKIPA Pharma
    HOOKIPA Pharma Appoints Mark Winderlich as Chief Development Officer to Lead Clinical Research and Development Organization
    16.01.24 · globenewswire · HOOKIPA Pharma
    Hookipa Pharma: +100% mit Ansage – wo lauern die nächsten Deals?
    22.12.23 · Sharedeals · HOOKIPA Pharma
    HOOKIPA Pharma Announces $21.25 Million Equity Investment from Gilead Sciences
    21.12.23 · globenewswire · HOOKIPA Pharma
    HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-500 for the Treatment of Human Immunodeficiency Virus
    20.11.23 · globenewswire · HOOKIPA Pharma